7.6.3	  Summary of evidence and guidelines for adjuvant therapy,
Recommendations,Strength rating
Offer adjuvant cisplatin-based combination chemotherapy to patients with pT3/4 and/or   pN+ disease if no neoadjuvant chemotherapy has been given.,Strong
"Offer adjuvant nivolumab to selected patients with pT3/4 and/or pN+ disease not eligible   for, or who declined, adjuvant cisplatin-based chemotherapy.",Weak
